Name: CSL (CSL) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

CSL

Pharmaceuticals, Biotechnology & Life Sciences

CSL Limited is a global biotechnology company specializing in the development, manufacturing, and marketing of life-saving biotherapies, vaccines, and diagnostic products. Its core business revolves around plasma-derived therapies, which treat a range of serious medical conditions, and recombinant technologies. CSL holds a leading market position in several therapeutic areas, leveraging its extensive research and development capabilities and global manufacturing and distribution network to deliver innovative healthcare solutions.

Short position

short percentage1.55%

reported shorts7.4M

shares on issue478.912M

CSL (ASX:CSL) has 1.55% of its shares on issue reported as short positions as of 24 Aug 2026, or about 7,431,003 shares. Over the past 30 days that figure has risen 0.58 percentage points, and over 90 days it has risen 0.91 percentage points. Its highest recorded short interest was 3.27% in June 2010. CSL is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.